• Publications
  • Influence
Are There Better Guidelines for Allocation in Liver Transplantation?: A Novel Score Targeting Justice and Utility in the Model for End-Stage Liver Disease Era
Objectives:To design a new score on risk assessment for orthotopic liver transplantation (OLT) based on both donor and recipient parameters. Background:The balance of waiting list mortality andExpand
  • 240
  • 24
  • PDF
Early Survival and Safety of ALPPS: First Report of the International ALPPS Registry
Objectives:To assess safety and outcomes of the novel 2-stage hepatectomy, Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS), using an international registry.Expand
  • 288
  • 14
  • PDF
ALPPS Offers a Better Chance of Complete Resection in Patients with Primarily Unresectable Liver Tumors Compared with Conventional-Staged Hepatectomies: Results of a Multicenter Analysis
BackgroundPortal vein occlusion to increase the size of the future liver remnant (FLR) is well established, using portal vein ligation (PVL) or embolization (PVE) followed by resection 4–8 weeksExpand
  • 202
  • 12
  • PDF
Prediction of Mortality After ALPPS Stage-1: An Analysis of 320 Patients From the International ALPPS Registry.
OBJECTIVES The aim of this study was to identify predictors of 90-day mortality after Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS), available after stage-1,Expand
  • 147
  • 6
Should ALPPS be Used for Liver Resection in Intermediate-Stage HCC?
BackgroundExtended liver resections in patients with hepatocellular carcinoma (HCC) are problematic due to hepatitis, fibrosis, and cirrhosis. Associating liver partition with portal vein ligationExpand
  • 59
  • 6
Salvage parenchymal liver transection for patients with insufficient volume increase after portal vein occlusion -- an extension of the ALPPS approach.
BACKGROUND Portal vein ligation (PVL) or embolization (PVE) are standard approaches to induce liver hypertrophy of the future liver remnant (FLR) prior to hepatectomy in primarily non-resectableExpand
  • 87
  • 5
  • PDF
ALPPS as a salvage procedure after insufficient future liver remnant hypertrophy following portal vein occlusion.
BACKGROUND A minimum future liver remnant (FLR) of 30% is required to avoid post hepatectomy liver failure (PHLF). Portal vein occlusion (PVO) is the main strategy to induce hypertrophy of the FLR,Expand
  • 16
  • 3
Systematic Review and Meta-Analysis of Feasibility, Safety, and Efficacy of a Novel Procedure: Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy
BackgroundAssociating liver partition and portal vein ligation for staged hepatectomy (ALPPS) is a novel strategy to resect liver tumors despite the small size of the liver remnant. It is anExpand
  • 99
  • 2
Monosegment ALPPS hepatectomy: extending resectability by rapid hypertrophy.
BACKGROUND Liver remnant function limits major liver resections to generally leave patients with ≥2 Couinaud segments. Associating Liver Partition and Portal vein ligation for Staged hepatectomyExpand
  • 67
  • 2
  • PDF
Strategies to Increase the Resectability of Patients with Colorectal Liver Metastases: A Multi-center Case-Match Analysis of ALPPS and Conventional Two-Stage Hepatectomy
BackgroundTwo-stage hepatectomy (TSH) is well established for the treatment of patients who have colorectal cancer liver metastases (CRLM) with a small liver remnant. The technique of associatingExpand
  • 80
  • 1